HOME >> MEDICINE >> NEWS
Revolutionary HIV drug Fuzeon wins most prestigious award for innovation

Revolutionary HIV drug Fuzeon wins most prestigious award for innovationToday, HIV drug Fuzeon (enfuvirtide or T-20) was awarded the 2004 International Prix Galien for the most innovative new medicine. Fuzeon was selected out of 12 major new drugs in all therapeutic areas which each won national awards. Since 1970 Roche has won a total of 24 international and national Prix Galien medals, notably winning the international award twice in the field of HIV. This reflects Roche's strong track record in innovation across its entire product portfolio.

"Fuzeon was considered as the clear winner by the whole jury because it represents a new therapeutic approach, in fact the only new class of antiretroviral HIV drugs to emerge in the last eight years. Fuzeon markedly contributes to a significant increase in patients' quality of life", said Professor Walter Osswald, the President of the International Prix Galien Jury.

"This distinguished award is another testimony to Roche's unique innovation capabilities enhancing the development of truly novel medicines; this also brings great pride and motivation to everyone at Roche", said William M. Burns, Head of Roche's Pharmaceuticals Division. "However, innovation is only one milestone of Fuzeon's success; the next crucial step is getting the drug to those who need it."

Fuzeon bringing the medicine to patients

Despite this acknowledgement of the drug as a huge technological advance, Roche's latest research showed that as many as 4 out of 5 eligible patients are missing the opportunity to benefit from this breakthrough. To ensure all eligible patients who need Fuzeon can benefit from the drug Roche is currently working with physicians, patient organisations and government agencies. Education programmes are leading to improved access. Within just three months, Fuzeon patients are twice as likely to achieve undetectable levels of virus in their blood compared to those who are not taking Fuzeon1<
'"/>

Contact: Alexander Watson
alexander.watson@ketchum.com
44-771-267-5990
Ketchum
8-Oct-2004


Page: 1 2

Related medicine news :

1. Revolutionary treatment for birth defect improves survival of newborns
2. Revolutionary New Procedure That Creates Controlled Heart Attack Performed For First Time In Southern California At Cedars-Sinai Medical Center
3. Standardization Of Revolutionary Cancer Treatment Offers Hope To Patients Nationwide
4. Penn addictions expert, Charles P. OBrien, MD, PhD, receives prestigious, international honor
5. University of Maryland School of Medicine scientist receives prestigious presidential award
6. Rising young psychiatry researchers receive prestigious international award
7. UCSD faculty elected to membership in prestigious professional organizations
8. UIC professor receives international humanitarian award
9. Northwestern Memorial Hospital honored with one of the nations top awards for quality
10. University of Manchester awarded 826k for brain science and mental health research
11. NASA awards $9.8 million NSCOR grant to UT Southwestern to study effects of space radiation exposure

Post Your Comments:
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... to impossible, but a new study adds to a ... CT scans may help spot the beginnings of disease ... the greatest risk for lung cancer, 6 percent were ... and follow-up biopsies to confirm the diagnosis. CT scans ...
(Date:5/21/2013)... Sunnyvale, California (PRWEB) May 21, 2013 ... invites individuals who are grieving to remember and honor ... an Evening of Remembrance Memorial Service, Sunday, June 2, ... at Skyline Boulevard, San Mateo, CA 94402. , ... non-denominational, and includes a short program with music, readings ...
(Date:5/21/2013)... Calif. (PRWEB) May 21, 2013 Not ... a dual diagnosis of Borderline Personality Disorder (BPD) and ... is proving to be successful for the treatment of ... 1, Alina Gorgorian, Ph.D., clinical director of Clearview ... in Los Angeles, will provide attendees of the West ...
(Date:5/21/2013)... more likely than their normal-weight counterparts to repeatedly ... continuity of care and leads to more emergency ... The practice of "doctor shopping" among overweight patients ... the health care system, whether that be off-putting ... by providers, or improperly sized medical equipment and ...
(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...
Breaking Medicine News(10 mins):Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2
(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue:   ... for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... to offer synopsis of the current and ...
(Date:5/21/2013)... , May 21, 2013  Healthcare organizations expanding into ... Russia , India ... there are no shortcuts.  This is proving particularly challenging, ... States.  Companies must change the dialogue around BRIC, as ... local needs, and building regional partnerships to build a ...
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ...   Summary ...
Breaking Medicine Technology:Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: